Lymphodepleting chemotherapy in order to safely improve the expansion of HER2CAR T cells in patients with advanced sarcomas
Lymphodepleting chemotherapy in order to safely improve the expansion of HER2-CAR T cells in patients with advanced sarcomas
Prof Shoba Navai speaks to ecancer at the 2019 American Association for Cancer Research (AACR) meeting about results from a study looking at lymphodepleting chemotherapy in order to safely improve the expansion of HER2-CAR T cells in patients with...
More From BioPortfolio on "Lymphodepleting chemotherapy in order to safely improve the expansion of HER2-CAR T cells in patients with advanced sarcomas"